Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Chemizon, a division of Optomagic, has received board approval for investing an additional $5 million in its Beijing operations for this fiscal year.
Subscribe to our email newsletter
This investment will be used to augment Chemizon Beijing’s integrated discovery platform by adding capabilities in the area of biology and computational chemistry.
Anthony Piscopio, president, CEO and chairman of Optomagic, said: “We are seeing a significant increase in interest from our partners to move towards value-added discovery collaborations in Asia.
“This additional investment will strengthen our discovery platform both by the addition of key hires to our management team and by expanding our capabilities in the area of discovery research.”